Skip to main content
Jacob Shreve, MD, Oncology, Rochester, MN, Cleveland Clinic

JacobTylerShreveMD

Oncology • Rochester, MN

Hematology Oncology fellow at Mayo Clinic. Currently excited to be leveraging artificial intelligence on cancer data.

Join to view full profile

Dr. Shreve is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Shreve's full profile

Already have an account?

Summary

  • Dr. Jacob Shreve is an oncologist in Rochester, MN and is affiliated with multiple hospitals in the area, including Cleveland Clinic and Mayo Clinic Hospital - Rochester. He received his medical degree from Indiana University School of Medicine and has been in practice 0 years. He is experienced in personalized medicine, genomics, artificial intelligence, and bioinformatics. He has more than 20 publications and over 500 citings.

Education & Training

  • Mayo Clinic College of Medicine and Science
    Mayo Clinic College of Medicine and ScienceFellowship, Hematology and Medical Oncology, 2021 - 2024
  • Cleveland Clinic Foundation
    Cleveland Clinic FoundationResidency, Internal Medicine, 2018 - 2021
  • Indiana University School of Medicine
    Indiana University School of MedicineClass of 2018

Certifications & Licensure

  • MN State Medical License
    MN State Medical License 2021 - 2024
  • OH State Medical License
    OH State Medical License 2018 - 2021
  • American Board of Internal Medicine Internal Medicine

Publications & Presentations

PubMed

Journal Articles

  • The evolving landscape of myelodysplastic syndrome prognostication  
    Shreve, J.T., Nazha, A., Clinical Hematology International, 4/1/2020

Abstracts/Posters

  • Predicting Response to Hypomethylating Agents in Patients with Myelodysplastic Syndromes (MDS) Using Artificial Intelligence (AI)
    Jacob Shreve, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Geno-Clinical Model for the Diagnosis of Bone Marrow Myeloid Neoplasms
    Jacob Shreve, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

  • A Personalized Prediction Model to Risk Stratify Patients with Acute Myeloid Leukemia (AML) Using Artificial Intelligence 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019

Hospital Affiliations

Dr. Jacob Shreve, Dr. Jacob Shreve, MD, Dr. J Shreve, Dr. Jacob Tyler Shreve